PP89 The Investigation And Development Of A National Formulary Monitoring System Across Wales

Introduction The New Treatment Fund (NTF), launched in January 2017, aims to support the faster introduction of new medicines recommended by National Institute for Health and Care Excellence (NICE) All Wales Medicines Strategy Group (AWMSG). NTF requires seven health boards one trust make available within 60 days any positive recommendation decision. project goal was develop a system demonstrating how monitoring improves access people Wales. Methods process derived via series task finish group meetings with relevant stakeholders. criteria were agreed through collaborative expert approach using nominal technique. This determined minimal dataset formulary status, which included time addition. Pre-NTF data (n = 59) six-month period. Results By three-year milestone NTF, average taken newly 219) become patients across had decreased eighty-five percent from 90 13 (p < 0.01). Conclusions An innovative robust has been created accurately addition supporting rapid comprehensive uptake deemed clinically cost effective NICE AWMSG.